Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2024-05-27 AGM Information
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Deposito del Verbale dell'Assemblea degli Azionisti
AGM Information Classification · 98% confidence The document is titled "DEPOSITO VERBALE DELL'ASSEMBLEA DEGLI AZIONISTI" (Filing of the Minutes of the Shareholders' Meeting) and states that the minutes from the Shareholders' Meeting held on April 29, 2024, are now available to the public at the registered office, on the website, and at the authorized storage mechanism. This explicitly indicates the publication of the official minutes from a general meeting. The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it is the minutes rather than a presentation, it is directly related to the AGM proceedings. Given the content is the formal record of the meeting, AGM-R is the most appropriate classification over a general Regulatory Filing (RNS). The document length is short (2997 chars), but it is the report itself (the minutes), not an announcement *about* the report's release, thus avoiding the RPA classification.
2024-05-27 Italian
Verbale dei lavori dell'Assemblea Ordinaria e Straordinaria degli Azionisti
Pre-Annual General Meeting Information Classification · 19% confidence
2024-05-27 Italian
The Board of Directors approves the Net Financial Position for the First Quarter of 2024
Earnings Release Classification · 98% confidence The document is a press release dated May 7, 2024, detailing the approval of the Net Financial Position as of March 31, 2024 (First Quarter), and providing updates on clinical trials (Nidlegy™, Fibromun, OncoFAP). The key financial component is the disclosure of the Net Financial Position table comparing Q1 2024 to FY 2023 year-end. This structure—a press release summarizing period-end financial metrics (like Net Financial Position) and operational updates—is characteristic of an Interim/Quarterly Report announcement, even though it is not the full statutory report itself. Since it focuses heavily on the Q1 financial position and operational progress, it aligns best with the Interim / Quarterly Report (IR) category, which covers comprehensive reports for periods shorter than a year. It is more detailed than a simple Earnings Release (ER) which usually only contains key highlights, and it is not merely an announcement of a report (RPA). Q1 2024
2024-05-07 English
Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al Primo Trimestre 2024
Interim / Quarterly Report Classification · 95% confidence The document is a press release from Philogen S.p.A. dated May 7, 2024. It provides a detailed update on the company's financial position (Net Financial Position) as of March 31, 2024, including a balance sheet table, and provides substantive updates on clinical trials and industrial programs. Because it contains actual financial data (Net Financial Position) and detailed operational analysis for a specific quarterly period (Q1 2024), it qualifies as an Interim/Quarterly Report (IR) rather than a simple announcement. Q1 2024
2024-05-07 Italian
Comunicato stampa Assemblea 29 aprile 2024
AGM Information Classification · 98% confidence The document explicitly details the resolutions passed during the 'Assemblea degli Azionisti 2024' (Shareholders' Meeting 2024). Key actions include approving the 2023 financial statements, approving the Remuneration Policy, appointing the new Board of Statutory Auditors (Collegio Sindacale), approving incentive plans (Stock Grant and Shareholding Plans), authorizing share buybacks, and approving a change to the bylaws regarding shareholder meeting intervention rights. These are the typical outcomes and discussions held during an Annual General Meeting (AGM). Since the document summarizes the results and decisions made at the meeting, the most appropriate classification is AGM Information (AGM-R). It is not a full 10-K, an Earnings Release (ER), or a proxy statement (PSI), but a summary of the meeting's outcomes.
2024-04-29 Italian
Informazioni sull'ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document title is "COMUNICAZIONE DELL'AMMONTARE COMPLESSIVO DEI DIRITTI DI VOTO" (Communication of the Total Amount of Voting Rights). It explicitly states the total number of voting rights and shares outstanding in preparation for an upcoming Shareholders' Meeting ('Assemblea degli Azionisti convocata per il giorno 29 aprile 2024'). This content directly relates to the official results or announcement of voting rights/share structure ahead of a general meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related announcements like the total voting capital.
2024-04-19 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.